Eric McDonald

Eric McDonald completed his education at Michigan State University, earning a BS degree in Biology in the mid 80’s. After graduation, he started with Parke-Davis Pharmaceuticals. The blockbuster medications Eric launched included Lipitor (atorvastatin), Lopid (gemfibrozil), and Cognex (tacrine). He quickly rose from the ranks of field sales to leadership, culminating with a directorship position. During his fourteen year tenure, he held positions in Sales Management, Sales Training, and Marketing Operations.

Following Pfizer’s acquisition of Parke-Davis, Eric went in to hold Director of Sales positions of 5 years each at Doak Dermatologics and Taro Pharma.

In 2013, Eric decided to engage in regenerative medicine. He began with T.A. Sciences and hasn’t looked back. Eric assumed the Director of Sales position and quickly articulated the domestic operations US, cultivating key opinion leaders within the Telomere Biology field.